dehydrogenas
key
enzym
catalyz
first
reaction
oxid
pentos
phosphat
pathway
therebi
provid
reduc
energi
cell
maintain
level
reduc
coenzym
nicotinamid
adenin
dinucleotid
phosphat
nadph
nadph
play
import
role
maintain
suppli
reduc
glutathion
counterbal
oxidantinduc
oxid
stress
redox
imbal
may
induc
cell
apoptosi
necrosi
thu
highlight
role
defend
oxid
damag
defici
preval
enzym
defect
human
affect
estim
million
peopl
worldwid
especi
popul
histor
expos
endem
malaria
common
clinic
manifest
neonat
jaundic
acut
hemolyt
anemia
caus
impair
erythrocyt
abil
remov
harm
oxid
stress
trigger
exogen
agent
drug
infect
fava
bean
ingest
hemolyt
anemia
caus
infect
subsequ
medic
clinic
import
concern
patient
defici
issu
primari
focu
mani
decad
relat
effort
understand
impact
plasmodium
infect
malaria
antimalari
drug
antimicrobi
druginduc
hemolysi
consid
common
advers
clinic
consequ
defici
also
demonstr
infect
caus
certain
virus
hepat
virus
b
e
cytomegaloviru
associ
hemolyt
anemia
patient
defici
recent
shown
infect
particular
virus
enteroviru
dengu
viru
coronaviru
enhanc
cell
howev
impact
bacteri
infect
patient
defici
still
remain
clarifi
studi
focus
investig
antibioticinduc
hemolysi
treatment
bacteri
infect
addit
case
report
show
infect
clostridium
difficil
may
trigger
hemolysi
led
sever
jaundic
neonat
anoth
case
report
describ
hemolysi
caus
acinetobact
baumannii
infect
wilmanski
colleagu
demonstr
hyperinflamm
increas
cytokin
level
caus
acut
endotoxemia
induc
inject
escherichia
coli
lipopolysaccharid
result
increas
mortal
mice
sever
studi
also
indic
defici
leukocyt
result
chronic
granulomat
diseas
cgd
possibl
alter
host
defens
mechan
bacteri
infect
thu
far
impact
bacteri
infect
patient
defici
found
primarili
affect
blood
cell
lead
hemolysi
immun
weak
base
upon
studi
bacteri
infect
treatment
septic
plasma
might
induc
mitochondri
dysfunct
accumul
reactiv
oxygen
speci
ro
nitric
oxid
radic
lymphocyt
epitheli
cell
lead
cell
apoptosi
therefor
propos
cell
defici
may
less
toler
oxid
stress
caus
bacteri
infect
present
studi
investig
direct
impact
bacteri
infect
epitheli
cell
use
staphylococcu
aureu
model
pathogen
aureu
long
recogn
major
caus
healthcareassoci
infect
result
sepsi
septic
shock
lead
vascular
damag
multipl
organ
failur
vancomycin
one
primari
choic
treat
infect
result
multidrugresist
aureu
includ
methicillinresist
aureu
mrsa
previou
studi
demonstr
vancomycintr
vancomycinresist
aureu
vrsa
strain
enhanc
cytotox
activ
altern
virul
express
whether
enhanc
even
stronger
cell
also
investig
studi
vancomycinresist
aureu
strain
gener
introduc
vancomycin
resistancecarri
plasmid
strain
atcc
describ
previous
briefli
p
r
vanrsp
h
haxp
vanyp
z
vanz
gene
cluster
van
operon
within
e
faecali
amplifi
clone
luxab
gene
remov
gener
bacteri
strain
routin
cultur
specif
requir
antibiot
sigma
bhi
broth
agar
plate
lung
carcinoma
cell
line
obtain
american
type
cultur
collect
atcc
deriv
cell
line
use
present
studi
stabl
cell
line
control
cell
line
transfect
pcineo
vector
gener
approv
kindli
given
dr
hungyao
ho
briefli
plasmid
gener
ligat
complementari
oligonucleotid
pcineo
mammalian
express
vector
follow
transfect
cell
gener
cell
cultur
dmem
gibco
brl
supplement
fetal
calf
serum
penicillin
uml
streptomycin
uml
humidifi
atmospher
air
infect
overnight
cultur
aureu
strain
dilut
back
subcultur
ml
bhi
broth
without
antibiot
bacteri
infect
cell
perform
inocul
multipl
infect
absenc
presenc
vancomycin
specifi
circumst
function
secret
aureu
inhibit
ad
oroxylin
sigma
infect
cell
cultur
humidifi
atmospher
air
use
sampl
observ
use
microscop
steril
glass
cover
slip
insert
well
advanc
vrsa
strain
grown
overnight
shake
bhi
broth
next
day
bacteri
cultur
dilut
fresh
bhi
broth
without
vancomycin
incub
shake
h
bacteria
plate
agar
enumer
surviv
cfu
timekil
curv
construct
plot
mean
coloni
count
cfuml
versu
time
three
experi
cell
viabil
test
perform
use
mtt
assay
cell
prolifer
reagent
mtt
tetrazolium
bromid
sigma
describ
previous
mtt
tetrazolium
ring
cleav
activ
mitochondria
yield
purpl
formazan
crystal
whose
amount
directli
correl
viabl
cell
count
h
postinfect
mgml
mtt
solut
ad
well
plate
incub
h
purpl
formazan
crystal
dissolv
ad
mtt
solubil
solut
sigma
absorb
spectrophotometr
measur
refer
wavelength
result
express
percent
absorb
experiment
well
versu
well
contain
untreat
cell
three
well
per
experiment
condit
count
three
independ
experi
format
intracellular
ro
visual
detect
dichlorofluorescein
dcf
deriv
oxid
dihydrodichlorofluorescein
previous
describ
h
postinfect
dichlorofluorescein
diacet
invitrogen
ad
well
min
examin
fluoresc
microscop
quantif
ro
format
perform
flow
cytometri
cell
treat
describ
follow
two
wash
pb
trypsin
treatment
flow
cytometr
data
analys
perform
describ
elsewher
mean
fluoresc
intens
mfi
dcf
channel
determin
use
cellquest
pro
softwar
becton
dickinson
result
express
fold
chang
percentag
increas
dcf
channel
cell
apoptosisnecrosi
visual
annexin
vfitcpropidium
iodid
pi
stain
commerci
apoptosi
detect
kit
biovis
microscopi
accord
manufactur
instruct
well
analysi
flow
cytometri
phosphatidylserin
transloc
apoptot
cell
stain
annexin
vfitc
show
green
fluoresc
wherea
nucleic
acid
dead
necrosi
cell
stain
pi
emit
red
fluoresc
dapi
employ
stain
cell
nucleu
produc
blue
fluoresc
h
postinfect
cell
wash
three
time
pb
microscopi
bind
buffer
ad
well
togeth
dapi
annexin
vfitc
pi
min
cover
slip
remov
observ
confoc
microscopi
flow
cytometri
analysi
cell
trypsin
follow
wash
pb
resuspend
bind
buffer
five
min
addit
annexin
vfitc
pi
flow
cytometri
analysi
perform
use
facscalilbur
bd
bioscienc
cell
excit
nm
laser
green
apoptot
cell
detect
nm
red
necrosi
cell
detect
nm
fluoresc
could
detect
live
cell
cell
show
green
red
fluoresc
consid
late
apoptosi
biochem
marker
apoptosi
also
detect
western
blot
analysi
cell
lyse
lysi
buffer
describ
elsewher
protein
concentr
lysat
determin
bradford
method
resolv
protein
lysat
sdspage
sampl
transfer
nitrocellulos
membran
block
milk
tb
contain
tween
tbst
membran
probe
primari
antibodi
mous
multiclon
sigma
gapdh
overnight
wash
tbst
membran
probe
secondari
hors
antimous
hrplink
antibodi
sigma
h
develop
use
ecl
reagent
bioman
blot
photograph
use
xomat
kodak
film
processor
student
ttest
nonparametr
test
use
analyz
experiment
data
compar
mean
pvalu
less
consid
statist
signific
understand
whether
epitheli
cell
less
toler
control
cell
bacteri
infect
mtt
assay
employ
evalu
cell
viabil
upon
aureu
infect
result
shown
figur
indic
cell
viabil
scrambl
control
cell
line
decreas
h
postinfect
howev
cell
viabil
significantli
less
p
cell
previous
demonstr
vancomycin
could
activ
vancomycinresist
staphylococcu
aureu
result
enhanc
cytotox
effect
vancomycintr
vrsa
infect
cell
counterpart
investig
addit
effect
observ
upon
vancomycin
treatment
either
scrambl
control
cell
figur
hypothes
cell
less
toler
oxid
stress
upon
bacteri
infect
lead
accumul
intracellular
ro
compar
control
scrambl
cell
confirm
directli
observ
dcf
intens
within
cell
fluoresc
microscopi
shown
figur
averag
level
green
fluoresc
intens
higher
vrsainfect
cell
untreat
cell
cell
line
even
stronger
fluoresc
intens
observ
among
vrsainfect
cell
among
cell
treatment
vancomycin
show
obviou
effect
fluoresc
intens
either
cell
line
upon
vrsa
infect
slight
increas
ro
product
observ
vancomycintr
control
cell
compar
vancomycinfre
cell
cell
line
product
ro
quantifi
determin
mfi
dcf
channel
infect
vrsa
result
increas
mfi
among
cell
respect
figur
signific
accumul
ro
product
cell
control
scrambl
cell
p
observ
upon
bacteri
infect
vancomycin
treatment
vrsainfect
cell
also
significantli
reduc
ro
accumul
cell
vancomycin
treatment
alon
show
slight
nonsignific
increas
ro
product
cell
line
figur
rule
reduc
ro
accumul
might
due
increas
bacteri
kill
upon
vancomycin
treatment
bacteri
kill
kinet
assay
perform
slower
bacteri
growth
observ
presenc
absenc
vancomycin
first
hour
signific
differ
seen
durat
experi
h
figur
addit
h
postinfect
aliquot
bacteriainfect
cell
cultur
media
remov
plate
agar
signific
differ
cfu
differ
experiment
condit
evid
data
shown
van
operoncarri
plasmid
also
found
coloni
indic
vancomycin
resist
construct
stabl
data
shown
whether
accumul
intracellular
ro
result
stronger
apoptot
activ
cell
investig
fluoresc
microscopi
result
shown
figur
indic
cell
show
apoptosi
necrosi
phenotyp
upon
vrsa
infect
wherea
apoptot
activ
weaker
cell
condit
vancomycin
treatment
vrsainfect
cell
appar
reduc
apoptot
activ
cell
detect
proport
pistain
cell
vancomycin
treatment
alon
signific
effect
apoptot
activ
either
cell
line
quantif
assay
apoptot
activ
evalu
flow
cytometri
percentag
apoptot
necrot
cell
increas
vrsainfect
cell
h
postinfect
percentag
significantli
higher
cell
p
control
scrambl
cell
figur
bottom
row
observ
microscop
vancomycin
treatment
vrsainfect
cell
significantli
reduc
percentag
apoptot
necrot
cell
cell
respect
detect
slight
nonsignific
increas
apoptot
activ
upon
vancomycin
treatment
alon
cell
figur
addit
morpholog
marker
biochem
marker
apoptosi
detect
western
blot
analysi
locat
key
junction
apoptosi
pathway
express
cell
compar
cell
upon
differ
treatment
result
shown
figur
indic
similar
level
cleav
kda
observ
upon
vrsavancomycintr
vrsa
infect
cell
suggest
similar
signal
strength
trigger
extrins
apoptot
pathway
weak
cleav
express
found
bacteriafre
cell
impli
cell
less
toler
extrins
death
ligand
cultur
hand
vrsa
infect
obvious
trigger
higher
express
precursor
kda
cleav
form
kda
thereaft
lead
higher
express
level
kda
cleav
kda
effector
caspas
cell
scrambl
control
cell
figur
result
suggest
stronger
intrins
apoptot
signal
trigger
cell
upon
bacteri
infect
addit
vancomycin
treatment
vrsainfect
cell
reduc
express
level
cleav
cell
line
figur
trace
non
express
observ
bacteriafre
cell
cultur
previous
show
decreas
hla
encod
express
hemolyt
activ
observ
strain
upon
vancomycin
treatment
determin
whether
reduc
ro
accumul
apoptot
activ
particularli
cell
due
deceas
express
upon
vrsa
infect
presenc
vancomycin
product
intracellular
ro
cell
apoptosi
inhibitor
oroxylin
ad
media
quantifi
flow
cytometri
hemolysi
inhibit
sjc
cell
inocul
blood
agar
plate
contain
either
oroxylin
vancomycin
figur
treatment
oroxylin
vancomycin
significantli
reduc
intracellular
ro
apoptot
activ
cell
line
presenc
infect
oroxylin
treatment
alon
show
signific
effect
accumul
ro
cell
apoptosi
figur
present
studi
demonstr
epitheli
cell
less
toler
aureu
infect
accumul
ro
lead
stronger
apoptot
activ
studi
patient
defici
mostli
focus
sever
hemolyt
anemia
extrem
hyperbilirubinemia
jaundic
bilirubin
encephalopathi
especi
neonat
describ
effect
infect
patient
defici
studi
mainli
regard
hemolyt
anemia
caus
plasmodium
infect
antimicrobi
drug
viral
bacteri
infect
addit
hemolyt
anemia
enhanc
viral
infect
immun
weak
neutrophil
dysfunct
also
address
studi
demonstr
direct
impact
bacteri
infect
epitheli
cell
result
contrast
found
blood
cell
lack
ro
product
phagocyt
neutrophil
monocyt
may
caus
chronic
granulomat
diseaselik
clinic
symptom
patient
defici
phagocyt
dysfunct
may
lead
recurr
infect
catalaseposit
microorgan
staphylococci
bacteria
could
phagocytos
digest
hand
demonstr
bacteri
infect
may
induc
oxid
stress
lymphocyt
mammari
epitheli
cell
yeast
consist
find
result
indic
intracellular
ro
gener
lung
carcinoma
cell
upon
aureu
infect
figur
propos
capac
ro
remov
impair
cell
follow
infectioninduc
oxid
stress
expect
accumul
ro
significantli
higher
cell
control
scrambl
cell
follow
exposur
vrsa
figur
therefor
impact
bacteri
infect
patient
defici
twofold
first
immun
weak
due
dysfunct
phagocyt
second
impair
ro
remov
upon
bacteri
infect
demonstr
epitheli
cell
well
demonstr
apoptosi
signalregul
kinas
member
mitogenactiv
protein
kinas
mapk
cascad
activ
upon
oxid
stress
lead
cell
apoptosi
demonstr
impair
ro
remov
cell
result
higher
apoptot
activ
control
scrambl
cell
figur
caspas
famili
cystein
proteas
play
essenti
role
apoptosi
classic
apoptot
machineri
involv
activ
initi
caspas
upon
death
signal
therebi
cleav
inact
proform
effector
caspas
activ
commenc
extrins
apoptot
pathway
depend
activ
bind
extracellular
death
ligand
transmembran
death
receptor
contrast
intrins
pathway
trigger
releas
cytochrom
c
mitochondria
therebi
activ
pathway
lead
activ
effector
caspas
result
present
indic
express
activ
well
downstream
much
higher
cell
control
scrambl
cell
upon
vrsa
infect
suggest
mitochondri
dysfunct
may
major
caus
increas
cell
apoptosi
figur
recent
studi
demonstr
incub
epitheli
cell
enterotoxin
isol
aeromona
veronii
increas
accumul
intracellular
ro
lead
loss
mitochondri
membran
potenti
thereaft
undergo
apoptosi
mitochondri
pathway
aureu
strain
use
studi
construct
atcc
strain
genet
background
known
lack
varieti
exotoxin
except
therefor
may
propos
could
caus
mitochondria
dysfunct
similar
found
veronii
highlight
much
wors
outcom
cell
upon
bacteri
infect
unlik
lack
mitochondria
peripher
red
blood
cell
rbc
impact
bacteri
infect
rbc
caus
hemolysi
cell
differ
patient
defici
previou
studi
demonstr
antibiot
treatment
drugresist
aureu
strain
would
appear
environment
stress
activ
stress
respons
transcript
factor
studi
vancomycin
induc
activ
led
altern
downstream
virul
gene
vrsa
strain
well
increas
cytotox
human
bronchial
epitheli
cell
increas
express
bacteri
bind
capac
decreas
express
associ
increas
activ
might
key
contributor
cytotox
howev
similar
result
observ
studi
cell
line
use
neither
knock
control
scrambl
cell
report
import
mediat
cytotox
cell
wherea
toler
cell
propos
major
caus
mitochondria
dysfunct
accumul
ro
cell
deriv
express
decreas
upon
vancomycin
treatment
impact
vancomycin
treatment
cytotox
vrsainfect
cell
obviou
either
knock
control
scrambl
cell
figur
fact
vancomycin
treatment
allevi
vrsa
infectionenhanc
ro
accumul
apoptosi
cell
even
though
cell
surviv
improv
figur
phenomenon
may
result
increas
bind
affin
vrsa
cell
upon
vancomycin
treatment
lead
stronger
cytotox
possibl
bypass
mitochondria
dysfunct
pathway
report
previous
therefor
net
impact
vancomycin
treatment
cell
surviv
presenc
infect
similar
vancomycinfre
condit
nevertheless
rule
misus
antibiot
drugresist
strain
trigger
express
exotoxin
caus
stronger
oxid
stress
cell
although
suscept
differ
cell
type
differ
bacteri
virul
factor
variabl
suppos
patient
defici
less
toler
bacteri
infect
conclus
demonstr
cell
damag
mechan
epitheli
cell
upon
bacteri
infect
cellular
ro
gener
mitochondria
varieti
mechan
reduc
accumul
ro
protect
oxid
stress
loss
mitochondri
membran
potenti
due
bacteri
infect
possibl
via
aureu
case
lead
increas
ro
product
cell
impair
reconvers
glutathion
disulphid
reduc
glutathion
caus
imbalanc
nadphnadp
redox
state
render
cell
unabl
remov
ro
effect
therefor
accumul
excess
ro
result
stronger
cell
apoptosi
mitochondri
pathway
one
import
clinic
concern
treat
bacteri
infect
patient
defici
avoid
usag
antibiot
caus
hemolyt
anemia
vancomycin
treatment
enhanc
vrsa
cytotox
toward
control
scrambl
cell
oppos
previous
observ
cell
